Cantor Fitzgerald lowered the firm’s price target on DocGo to $5 from $11 and keeps an Overweight rating on the shares. The firm is encouraged to hear that DocGo is realigning its focus to the base business and the lowered price target reflects the new vision for the company, not less confidence, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO:
- DocGo price target lowered to $6.50 from $8 at Stifel
- DocGo price target lowered to $9 from $10 at Canaccord
- DocGo signs extension, starts transition of asylum seeker contract with NYC HPD
- DocGo contract transition could remove overhang, says Canaccord
- DocGo’s Subsidiary Renews NYC Asylum Seeker Support Contract